Abstract:BACKGROUND: To evaluate the application value of artificial intelligence-based auxiliary diagnosis for congenital heart disease.METHODS: From May 2017 to December 2019, 1892 cases of congenital heart disease heart sounds were collected for learning- and memory-assisted diagnosis. The diagnosis rate and classification recognition were verified in 326 congenital heart disease cases. Auscultation and artificial intelligence-assisted diagnosis were used in 518 258 congenital heart disease screenings, and the detection accuracies of congenital heart disease and pulmonary hypertension were compared.RESULTS: Female sex and age > 14 years were predominant in atrial septal defect (P <.001) compared with ventricular septal defect/patent ductus arteriosus cases. Family history was more prominent in patent ductus arteriosus patients (P <.001). Compared with no pulmonary arterial hypertension, a male predominance was seen in cases of congenital heart disease-pulmonary arterial hypertension (P <.001), and age was significantly associated with pulmonary arterial hypertension (P =.008). A high prevalence of extracardiac anomalies was found in the pulmonary arterial hypertension group. A total of 326 patients were examined by artificial intelligence. The detection rate of atrial septal defect was 73.8%, which was different from that of auscultation (P =.008). The detection rate of ventricular septal defect was 78.8, and the detection rate of patent ductus arte-riosus was 88.9%. A total of 518 258 people from 82 towns and 1220 schools were screened including 15 453 suspected and 3930 (7.58%) confirmed cases. The detection accuracy of artificial intelligence in ventricular septal defect (P =.007) and patent ductus arteriosus (P =.021) classification was higher than that of auscultation. For normal cases, the recurrent neural network had a high accuracy of 97.77% in congenital heart disease-pulmonary arterial hypertension diagnosis (P =.032).CONCLUSION: Artificial intelligence-based diagnosis is an effective assistance method for congenital heart disease screening.

EP09.12: Use of artificial intelligence for automatic antenatal classification of congenital heart diseases

EP01.26: Diagnostic performance of antenatal diagnosis of congenital heart disease with artificial intelligence versus trained specialists

EP09.64: Artificial intelligence in evaluation of the fetal heart

OP02.09: AIRFRAME: artificial intelligence for recognition of fetal brain anomalies from ultrasound images of the first trimester

OP02.05: AI‐enhanced detection of congenital heart disease suspicion in second trimester ultrasounds by OBGYN and MFM

Data for AI in Congenital Heart Defects: Systematic Review

Artificial intelligence in fetal echocardiography: Recent advances and future prospects

Advances in the Application of Artificial Intelligence in Fetal Echocardiography

EP09.13: Congenital heart diseases unrecognised in the prenatal period: is the quality of obstetrical ultrasound related to the type of heart disease?

EP01.19: Performance of an AI software in automatic detection of fetal ultrasound planes

EP01.51: Artificial intelligence in the optimisation of the quality of ultrasound images

Applications of artificial intelligence-powered prenatal diagnosis for congenital heart disease

Artificial Intelligence in Obstetric Anomaly Scan: Heart and Brain

EP01.21: Performance evaluation study of an artificial intelligence‐based support system for fetal cardiac ultrasound screening

EP01.08: Artificial intelligence to assist in the screening fetal anomaly ultrasound scan (PROMETHEUS): a randomised controlled trial

[Artificial Intelligence Technology in Cardiac Auscultation Screening for Congenital Heart Disease: Present and Future].

EP01.41: Performance of an AI software in automatic detection of quality criteria and characteristics on fetal ultrasound images

Artificial Intelligence in Congenital Heart Disease

EP01.07: Robust and accurate measurement of semilunar valves in second trimester fetal ultrasound using an AI system

EP01.12: AI demonstrates high detection in first trimester screening for spina bifida

Application of Artificial Intelligence-Based Auxiliary Diagnosis in Congenital Heart Disease Screening